⌘K

Login Start Free

Home/Filings/4/0001144204-18-002949

4//SEC Filing

Huertas Pedro 4

Accession 0001144204-18-002949

CIK 0001035354other

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 9:25 AM ET

Size

5.5 KB

Accession

0001144204-18-002949

Insider Transaction Report

Form 4

Period: 2018-01-15

Eloxx Pharmaceuticals, Inc.ELOX

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2018-01-15+50,000→ 50,000 total
Exercise: $6.65Exp: 2028-01-15→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option vests over a four-year period commencing on January 15, 2018 in sixteen equal quarterly installments.

Documents

1 file

4
tv483653_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Eloxx Pharmaceuticals, Inc.

CIK 0001035354

Entity typeother

Related Parties

1

filerCIK 0001389517

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 9:25 AM ET
Size: 5.5 KB

View on SEC.gov